The pan-PPAR agonist Lanifibranor improves increased portal pressure, endothelial dysfunction and liver histology in a rat model of early NAFLD
Shivani Chotkoe, Yao Liu, Guillaume Wettstein et al. · Journal of Hepatology · 2023
Cited by 2 works. doi:10.1016/s0168-8278(23)02201-8